Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus
- PMID: 977992
- DOI: 10.1093/infdis/134.3.211
Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus
Abstract
Fifteen infants with pneumonia caused by respiratory syncytial virus (RSV) and 19 infants with bronchiolitis caused by RSV were studied for the influence of homologous, circulating neutralizing antibody on the severity of their illness. All infants were under nine months of age. Although maternal neutralizing antibody did not prevent infection with RSV and illness, the severity of pneumonia caused by RSV was inversely related to the level of neutralizing antibody. The severity of bronchiolitis caused by RSV was unrelated to maternal antibody levels. Chest roentgenograms showed pneumonia to be slightly more severe than bronchiolitis. Neither the severity of illness nor the presence of maternal neutralizing antibody was related to the development of complement-fixing antibody.
Similar articles
-
The immunologic response to infection with respiratory syncytial virus in infants.J Infect Dis. 1978 Jul;138(1):24-32. doi: 10.1093/infdis/138.1.24. J Infect Dis. 1978. PMID: 355574
-
In Vitro Enhancement of Respiratory Syncytial Virus Infection by Maternal Antibodies Does Not Explain Disease Severity in Infants.J Virol. 2017 Oct 13;91(21):e00851-17. doi: 10.1128/JVI.00851-17. Print 2017 Nov 1. J Virol. 2017. PMID: 28794038 Free PMC article.
-
[Bronchiolitis caused by respiratory syncytial virus in very young infants and transmitted maternal antibodies].Arch Fr Pediatr. 1988 Dec;45(10):791-3. Arch Fr Pediatr. 1988. PMID: 3071286 Review. French.
-
T - helper2 /T - helper1 imbalance in respiratory syncytial virus bronchiolitis in relation to disease severity and outcome.Egypt J Immunol. 2008;15(2):153-60. Egypt J Immunol. 2008. PMID: 20306698
-
Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus.Prog Med Virol. 1980;26:94-118. Prog Med Virol. 1980. PMID: 6999535 Review. No abstract available.
Cited by
-
Immunity to human and bovine respiratory syncytial virus.Arch Virol. 1990;112(1-2):1-25. doi: 10.1007/BF01348982. Arch Virol. 1990. PMID: 2196033 Review.
-
Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development.Front Immunol. 2019 Jul 25;10:1675. doi: 10.3389/fimmu.2019.01675. eCollection 2019. Front Immunol. 2019. PMID: 31402910 Free PMC article. Review.
-
Strategic priorities for respiratory syncytial virus (RSV) vaccine development.Vaccine. 2013 Apr 18;31 Suppl 2(Suppl 2):B209-15. doi: 10.1016/j.vaccine.2012.11.106. Vaccine. 2013. PMID: 23598484 Free PMC article. Review.
-
Correlates of Protection Against Respiratory Syncytial Virus Infection in Infancy.Clin Rev Allergy Immunol. 2022 Dec;63(3):371-380. doi: 10.1007/s12016-022-08948-8. Epub 2022 Jun 11. Clin Rev Allergy Immunol. 2022. PMID: 35689745 Review.
-
Prevalence of neutralizing antibody to respiratory syncytial virus in sera from mothers and newborns residing in the Gambia and in The United States.Clin Diagn Lab Immunol. 1996 Jul;3(4):477-9. doi: 10.1128/cdli.3.4.477-479.1996. Clin Diagn Lab Immunol. 1996. PMID: 8807217 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources